Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,956 total articles

United Community Banks, Inc. Announces Date for Second Quarter 2026 Earnings Release and Conference Call

United Community Banks, Inc. Announces Date for Second Quarter 2026 Earnings Release and Conference Call

United Community Banks, Inc., a top-100 U.S. financial institution, announced it will release its second quarter 2026 financial results before market open on July 21, 2026, followed by a conference call to discuss results, business highlights, and outlook. The company is recognized for its strong retail banking customer satisfaction and numerous in…

Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline

Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline

Liminatus Pharma amended its merger agreement with InnocsAI to allow closing prior to stockholder approval, expected July 2, 2026. The deal values InnocsAI at approximately $320 million, combining Liminatus common stock and new non-voting convertible preferred stock. The merger expands Liminatus' oncology cell therapy pipeline and immunotherapy pro…

TransAlta to Host Second Quarter 2026 Results Conference Call

TransAlta to Host Second Quarter 2026 Results Conference Call

TransAlta Corporation will release its second quarter 2026 financial results before market open on July 31, 2026, followed by a conference call/webcast for investors and analysts. The company is a major power generator operating in Canada, the US, and Western Australia, and emphasizes its diverse energy portfolio and approach to evolving energy sys…

Result of Annual General Meeting

Result of Annual General Meeting

Biodexa Pharmaceuticals PLC, a clinical stage biopharmaceutical company listed on NASDAQ under ticker BDRX, announced the results of its re-scheduled Annual General Meeting held on June 30, 2026. Seven ordinary resolutions passed with strong majority support, while certain key resolutions (8, 10, and 11) failed to pass, indicating mixed shareholder…

DLH Announces Leadership Transition

DLH Announces Leadership Transition

DLH Holdings Corp., a government services and technology firm, announced a leadership transition with CEO Zach Parker retiring, Kathryn JohnBull appointed as new CEO, and Steve Oroho as CFO. Parker will remain as advisor and board member to ensure a smooth transition. The Board expresses confidence in the new leadership team to advance DLH's strate…

Micware Co., Ltd. Announces Fiscal Year 2026 Financial Results

Micware Co., Ltd. Announces Fiscal Year 2026 Financial Results

Micware Co., Ltd., a Japan-based automotive software provider, announced a 3.7% revenue increase to JPY21.9 billion and a 19.6% net income rise for fiscal year 2026. The company successfully completed its IPO on the Nasdaq Global Market under ticker MWC in May 2026, raising $26.2 million. Micware aims to enhance its market position by evolving from…

Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape

Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape

Amarin Corporation highlights the continued clinical and economic value of VASCEPA® (icosapent ethyl) in managing severe hypertriglyceridemia and cardiovascular risk, despite the recent FDA approval of high-cost injectable APOC3 therapies. The company emphasizes VASCEPA's proven efficacy, affordability, broad access, and guideline support as vital …

Pelthos Therapeutics Added to Russell 3000E™ Growth Benchmark, Russell Microcap® and Russell Microcap® Growth Benchmark Indexes

Pelthos Therapeutics Added to Russell 3000E™ Growth Benchmark, Russell Microcap® and Russell Microcap® Growth Benchmark Indexes

Pelthos Therapeutics Inc. has been included in the Russell 3000E Growth Benchmark, Russell Microcap, and Russell Microcap Growth Benchmark Indexes following the 2026 Russell US Indexes reconstitution. This inclusion reflects the company's progress and growth as it advances its commercial-stage biopharmaceutical portfolio. It is expected to enhance …

FinWise Bancorp to Host Second Quarter 2026 Earnings Conference Call and Webcast on Wednesday, July 29, 2026

FinWise Bancorp to Host Second Quarter 2026 Earnings Conference Call and Webcast on Wednesday, July 29, 2026

FinWise Bancorp announced it will release its financial results for the second quarter of 2026 and host a conference call and webcast on July 29, 2026. The company provides banking and payment solutions for fintech brands and offers lending programs including SBA loans and commercial real estate financing, while expanding its payments and BIN spons…